Coaching for HCV and HIV

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 20, 2020

Primary Completion Date

January 28, 2022

Study Completion Date

January 28, 2022

Conditions
Hepatitis CHIV InfectionsOpioid-use Disorder
Interventions
OTHER

PRC brief motivational interview intervention

The intervention will involve the following elements: establishing rapport, asking permission to discuss drugs, discussing the pros and cons associated with drug use, uncovering the gaps between current and desired quality of life and determining readiness to change. The intervention will last approximately 20 minutes and take place at the time of the clinical visit while participants are waiting to be seen by a clinician or are awaiting laboratory testing.

OTHER

Phone contact

The PRC will remain in at least weekly contact by phone with each participant.

Trial Locations (1)

02118

Boston Medical Center - Low-Barrier-Access (LBA) walk-in clinic, Boston

Sponsors
All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Boston University

OTHER

lead

Boston Medical Center

OTHER

NCT04314414 - Coaching for HCV and HIV | Biotech Hunter | Biotech Hunter